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Dear Editor,
With great pleasure I read the letter by Nicolas Desse et al.
entitled BCranioplasty after decompressive craniectomy:
about bone flap preservation.^ The authors report yet unpub-
lished data from their own department, which do not
completely go along with the results presented by our own
workgroup in the February 2015 issue of the journal [1]. In
a series of 65 patients operated between January 2010
and December 2013, they find major bone flap resorption in
only two cases (7.1 %). They discussed that these two belong
to a well-known high-risk group for bone flap resorption be-
ing young (18 and 33 years old) and undergoing removal of a
very large bone flap that was stored and reimplanted in
segments.
The difference in our observations stresses the point that
there is need for a prospective multicentric study that analyzes
the outcome and complications after reimplantation of
cryoconserved bone flaps. In that point there is agreement
between Desse et al. and ourselves.
For that reason, we started a prospective multicentric study
in January 2015 in Switzerland, to which nearly all of the large
and medium-sized Swiss centers agreed to contribute. The
study is registered in clinicaltrials.gov under the identifier
NCT02320955 and is named BSwiss Prospective Autologous
bone flap Resorption Study (SPARS)^.
We intend to include 125 patients who underwent reimplan-
tation of their autologous cryoconserved bone flap after decom-
pressive craniectomy. In addition to routine follow-up, they will
receive native CT scans 12 and 24 months after reimplantation.
Primary endpoint is the incidence of a relevant resorption after
12 months, measured subjectively using the bone flap resorp-
tion score we proposed in BWhat happens to the bone flap?
Long-term outcome after reimplantation of cryoconserved bone
flaps in a consecutive series of 92 patients^ [1] and objectively
by volumetric subtraction of the 12- and 24-month postopera-
tive CT scans from the early postoperative one.
Secondary endpoints will be parameters of storage,
cryoconservation, fixation, and others.
We hope to finish patient inclusion by the end of 2016 and
be able to report the results after finishing the last follow-up in
2018/2019.
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